$500m CartiHeal sale to go ahead after FDA approval granted
US orthologics firm Bioventus (Nasdaq: BVS) can now proceed with its $500 million acquisition of CartiHeal, ...
Read moreUS orthologics firm Bioventus (Nasdaq: BVS) can now proceed with its $500 million acquisition of CartiHeal, ...
Read more Copyright © 2021 198 China News.
All Rights Reserved.
Copyright © 2021 198 China News.
All Rights Reserved.